Insights on Pharmaceuticals & Medical Products


A new IT operating model to better serve employees

– In this interview, Johnson & Johnson’s CIO of Corporate Technology explains how IT transformed the employee experience—and itself— with a digital-product mindset.

Infographic: Capital landscape for European biotechs is maturing, but it continues to trail the United States

– Europe’s biotech sector has made meaningful progress in attracting capital. However, raising more capital will be essential... to the continued growth of this sector.

Infographic: Building the European biotech sector with world-class science and innovation

– Europe is a powerhouse in scientific publishing with roughly twice the output of the United States and three times that of China.

Infographic: Biotech hot spots in a fragmented European landscape

– We mapped out 1,382 biotechs based in Europe and some interesting themes emerged.

How could gene therapy change healthcare in the next ten years?

– Cell and gene therapies are at the forefront of innovation and transforming how we treat and potentially cure certain diseases.... What will the next decade hold for these life-changing therapies?

Roche’s Infinity model: Helping to transform the lives of patients with rare diseases

– Anne Nijs explains how the rare-disease group at Roche Pharmaceuticals pioneered a new model that puts the patient experience... at the center of healthcare innovation and delivery.
Executive Briefing

COVID-19: Implications for business

– Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare... for the next normal.

Using digital tech to support employees’ mental health and resilience

– Poor mental health takes a heavy toll on individuals and businesses. New digital solutions can help employers provide personalized... support and make well-being a strategic focus for their organization.

Can European biotechs achieve greater scale in a fragmented landscape?

– World-class science and innovation need to be matched with stronger scale-up capabilities and a broader funding base if Europe... is to emerge as a leader in biotech.

Special collection

Future of pharma operations

Pharma companies are experiencing a wave of innovations – from new treatment modalities, to smart machines, advanced analytics, and digital connectivity. This selection of articles presents strategies and insights to capitalize on these innovations and advance quality, efficiency, resilience, and workforce agility in pharma operations. Contact us to learn more.

Coronavirus vaccines progress: What’s next?

The rapid development of the COVID-19 vaccines is having a profound effect on the world. This collection takes a closer look at the development, rollout and future of vaccines.

McKinsey insights on cell and gene therapy

Continuing advances in cell and gene therapy (CGT) are transforming how biopharma companies treat and potentially cure certain diseases. Browse our collection of articles for an in-depth look at the opportunities, challenges, and implications for stakeholders in this fast-evolving field, and explore how McKinsey’s new Digital Capability Center for Cell and Gene Therapy will help biopharma companies accelerate digital transformations in manufacturing and the journey to operational excellence. Contact us to learn more.

The rise of health technology

Health technology continues to push the boundaries of how healthcare is delivered and has the power to create breakthroughs in our understanding of disease. This collection of articles and interviews explores the evolving role of health technology in the life-sciences sector and implications for key stakeholders. Contact us to learn more about our work in this field.

Want to learn more about how we help clients in Pharmaceuticals & Medical Products?

More insights

Executive Briefing

COVID-19: Implications for business

– Our latest perspectives on the coronavirus outbreak, the twin threats to lives and livelihoods, and how organizations can prepare... for the next normal.

The next wave of innovation in photonics

– More end products are integrating lasers with sensors and optics, opening new opportunities for photonics manufacturers.

Sleep on it: Addressing the sleep-loss epidemic through technology

– Sleep deprivation has become a global problem. Can the burgeoning sleep-tech industry provide solutions?

Pharma’s digital Rx: Quantum computing in drug research and development

– Quantum computing’s ability to simulate larger, more complex molecules could be game changing. Pharmaceutical companies... should reflect on their strategic stance to this promising new technology now.

No place like home? Stepping up the decentralization of clinical trials

– The COVID-19 pandemic has catalyzed the adoption of decentralized clinical trials while highlighting the critical benefits of... virtual trials and improving the patient and physician experience.

An inflection point for biosimilars

– With rising US adoption, biosimilars are gathering even more momentum. Successful companies will innovate their commercial models,... rethink their portfolio management, and accelerate their R&D.

India’s tragedy reverberates around the world

– The COVID-19 crisis in India offers a stark reminder that what’s happening there could happen anywhere.

Not the last pandemic: Investing now to reimagine public-health systems

– The COVID-19 crisis reminds us how underprepared the world was to detect and respond to emerging infectious diseases. Smart investments... of as little as $5 per person per year globally can help ensure far better preparation for future pandemics.

The road to digital transformation: Roles and requirements for organizational success

– A panel of pharma digital leaders discusses pathways for technology and data scale-up—and the skills, mindsets, and C-suite influences... needed to drive true digital transformation.
Article - McKinsey Global Institute

How keeping health a priority is a prescription for European prosperity

– As Europe emerges from the pandemic, investing in health can not only save lives and build greater resilience but underpin economic... growth and prosperity.

Omnichannel engagement in medtech: The time is now

– Leading medtech companies are shifting to omnichannel models to build personalized engagement and stronger relationships with... healthcare professionals, which will ultimately translate into better care for patients.
Sorry, we couldn't find any results. Try removing some filters.

Connect with our Pharmaceuticals & Medical Products Practice